Michael Morrissey - 24 Feb 2026 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
President and CEO, Director
Signature
/s/ Nina Ayer, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
24 Feb 2026
Net transactions value
$0
Form type
4
Filing time
02 Mar 2026, 19:59:14 UTC
Previous filing
18 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Michael Morrissey filed Form 4 for EXELIXIS, INC. (EXEL) on 02 Mar 2026."

Quick Takeaways

  • This page summarizes Michael Morrissey's Form 4 filing for EXELIXIS, INC. (EXEL).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 02 Mar 2026, 19:59.

What Changed

  • Previous filing in this sequence was filed on 18 Feb 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MORRISSEY MICHAEL President and CEO, Director C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA /s/ Nina Ayer, Attorney in Fact 02 Mar 2026 0001202096

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Gift $0 -100,278 -4.8% $0.000000 1,989,956 24 Feb 2026 By Trust F1, F2
transaction EXEL Common Stock Award $0 +160,437 +11% $0.000000 1,614,552 26 Feb 2026 Direct F3, F4
holding EXEL Common Stock 17,728 24 Feb 2026 By 401(k) F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 24, 2026, the Reporting Person gifted 100,278 shares of Exelixis, Inc. common stock ("Common Stock") to the Bombora Rise Foundation.
F2 Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F3 Represents shares of Common Stock that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested.
F4 Includes 1,614,552 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F5 Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 26, 2026.

Sponsored